These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7590419)

  • 41. A preliminary multicentre study of the treatment of recently diagnosed type 1 diabetes by combination nicotinamide-cyclosporin therapy.
    Vialettes B; Picq R; du Rostu M; Charbonnel B; Rodier M; Mirouze J; Vexiau P; Passa P; Pehuet M; Elgrably F
    Diabet Med; 1990; 7(8):731-5. PubMed ID: 2147636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Long-term remission in fresh acute diabetes mellitus].
    Mirouze J; Renard E; Rodier M
    Presse Med; 1987 Oct; 16(32):1570-3. PubMed ID: 2958831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Remission of diabetes mellitus].
    Tanaka Y; Kashiwagi A; Shigeta Y
    Nihon Rinsho; 1991 Feb; 49 Suppl():398-404. PubMed ID: 1827849
    [No Abstract]   [Full Text] [Related]  

  • 44. The honeymoon phase - what we know today about the factors that can modulate the remission period in type 1 diabetes.
    Sokołowska M; Chobot A; Jarosz-Chobot P
    Pediatr Endocrinol Diabetes Metab; 2016; 22(2):66-70. PubMed ID: 28329775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclosporin therapy for prevention and cure of IDDM. Epidemiological perspective of benefits and risks.
    Lipton R; LaPorte RE; Becker DJ; Dorman JS; Orchard TJ; Atchison J; Drash AL
    Diabetes Care; 1990 Jul; 13(7):776-84. PubMed ID: 2201500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between physical activity before diagnosis and the presence of clinical remission in type 1 diabetes - InlipoDiab1 study.
    Flotyńska J; Jaz K; Cieluch A; Grzelka-Woźniak A; Kaczmarek A; Pypeć A; Ciepłucha W; Nowicka A; Zozulińska-Ziółkiewicz D; Uruska A
    Diabetes Metab Res Rev; 2022 Mar; 38(3):e3510. PubMed ID: 34729892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Remission Phase in Type 1 Diabetes: Role of Hyperglycemia Rectification in Immune Modulation.
    Tang R; Zhong T; Wu C; Zhou Z; Li X
    Front Endocrinol (Lausanne); 2019; 10():824. PubMed ID: 31849842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Depleting T cells in newly diagnosed autoimmune (type 1) diabetes--are we getting anywhere?
    Lernmark Å
    Diabetes; 2013 Nov; 62(11):3669-70. PubMed ID: 24158996
    [No Abstract]   [Full Text] [Related]  

  • 49. Case Study: Remission of Type 2 Diabetes After Outpatient Basal Insulin Therapy.
    Schmidt SC; Ann Huey M; Whitley HP
    Diabetes Spectr; 2016 Feb; 29(1):50-3. PubMed ID: 26912966
    [No Abstract]   [Full Text] [Related]  

  • 50. Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery.
    Taylor R; Al-Mrabeh A; Zhyzhneuskaya S; Peters C; Barnes AC; Aribisala BS; Hollingsworth KG; Mathers JC; Sattar N; Lean MEJ
    Cell Metab; 2018 Oct; 28(4):667. PubMed ID: 30282047
    [No Abstract]   [Full Text] [Related]  

  • 51. Retraction. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue.
    Lee HC; Kim KS; Shin HC
    Nature; 2009 Apr; 458(7238):660. PubMed ID: 19340080
    [No Abstract]   [Full Text] [Related]  

  • 52. C-2 monitoring for cyclosporin: considerations for implementation.
    Zolezzi M
    Saudi J Kidney Dis Transpl; 2004; 15(2):119-24. PubMed ID: 17642761
    [No Abstract]   [Full Text] [Related]  

  • 53. Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia.
    Sanchez-Pernaute O; Romero-Bueno FI; Selva-O'Callaghan A
    Reumatol Clin; 2021 Nov; 17(9):555-557. PubMed ID: 32354685
    [No Abstract]   [Full Text] [Related]  

  • 54. The Association of Autoimmune Diseases with Type 1 Diabetes Mellitus in Children Depends Also by the Length of Partial Clinical Remission Phase (Honeymoon).
    Ozen G; Zanfardino A; Confetto S; Piscopo A; Casaburo F; Tinto N; Iafusco F; Ozen G; Miraglia Del Giudice E; Tasar MA; Yilmaz A; Iafusco D
    Int J Endocrinol; 2020; 2020():2630827. PubMed ID: 32215008
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Remission of diabetes during conventional insulin therapy or therapy controlled by use of an artificial pancreas].
    Mirouze J; Selam JL; Pham TC; Mendoza E
    Sem Hop; 1979 Feb 18-25; 55(7-8):354-9. PubMed ID: 220725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of cyclosporine on insulin binding to erythrocytes in type 1 diabetes mellitus of recent onset.
    Behme MT; Dupre J; Stiller CR
    Clin Invest Med; 1988 Apr; 11(2):113-22. PubMed ID: 3293865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of methylprednisolone pulse therapy on insulin injections in patients with insulin-dependent diabetes mellitus.
    Satman I; Fiçicioğlu C; Karşidağ K; Yilmaz T; Dinçdağ N; Koca F; Odabaşi F; Aydin A; Devrim S; Haktan M
    Turk J Pediatr; 1996; 38(4):419-29. PubMed ID: 8993171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors predicting remission in type I diabetes.
    Pelkonen R; Aro A
    Ann Clin Res; 1984; 16(2):94-7. PubMed ID: 6380392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Use of cyclosporin A for remission induction in newly-detected insulin-dependent diabetes].
    Zamaklar M; Lalić N; Djordjević P; Dragasević M; Vujosević S; Savić K; Kalimanovska V
    Glas Srp Akad Nauka Med; 1994; (44):89-100. PubMed ID: 7590419
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.